Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Azithromycin measurement |
Component |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin poisoning (disorder) |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Accidental azithromycin poisoning |
Causative agent (attribute) |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Intentional azithromycin poisoning |
Causative agent (attribute) |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
intoxication par l'azithromycine d'intention indéterminée |
Causative agent (attribute) |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin adverse reaction |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Allergy to azithromycin (finding) |
Causative agent (attribute) |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin overdose |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Accidental azithromycin overdose |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Intentional azithromycin overdose |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
surdose d'azithromycine d'intention indéterminée |
Causative agent (attribute) |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin dihydrate 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin 1g/packet oral |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin dihydrate |
Is a |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Product containing azithromycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing azithromycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Accidental azithromycin poisoning |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Intentional azithromycin poisoning |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin 2g/60mL microspheres for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin 1% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Product containing azithromycin in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Allergy to azithromycin (finding) |
Causative agent (attribute) |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin (as azithromycin dihydrate) 250 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin monohydrate (substance) |
Is a |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin dihydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Azithromycin monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing azithromycin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing only azithromycin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing only azithromycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing only azithromycin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 33.3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 33.3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
|
Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 600 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 600 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |
Azithromycin 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin (substance) |
Inferred relationship |
Some |
1 |